Mounjaro®
Starting from £179.99/mo
Start journey Learn moreOn Mounjaro injections, no foods are strictly forbidden, but the evidence is clear that what you eat shapes how well treatment works. Tirzepatide slows gastric emptying and reduces appetite, so smaller, protein-rich, lower-fat meals tend to feel more comfortable and support more consistent weight loss. These are prescription-only medicines; a prescriber assesses whether they're right for you before any treatment begins. The guidance below draws on what the SURMOUNT clinical programme and NHS tirzepatide guidance tell us about eating patterns during treatment — practical, evidence-informed, and straightforward.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Every participant in the SURMOUNT-1 trial (which randomised 2,539 adults with obesity over 72 weeks) received structured diet and activity counselling alongside tirzepatide or placebo. The average body-weight reduction at the highest dose reached around 20–21%, a result that was built on a calorie-reduced diet, not achieved despite one. That detail matters. The published SURMOUNT-1 paper in the New England Journal of Medicine makes clear that lifestyle support was a designed component, not an optional add-on.
What that means practically: tirzepatide changes the internal environment (appetite, fullness, the speed at which your stomach empties) but it does not choose your meals. Eating patterns that work with those changes, rather than against them, consistently produced better outcomes in participants. The medicine reduces how much you want to eat; the quality of what you eat still matters.
Protein adequacy was a particular focus in the trial's nutritional guidance. When weight falls quickly, some of it can come from muscle rather than fat unless protein intake is protected. Aiming for a protein-containing food at every meal (eggs, lean meat, fish, dairy, legumes, tofu) helps preserve lean mass during active weight loss. This isn't a rigid prescription; it's a principle worth building meals around.
Because tirzepatide already slows gastric emptying as part of how it works, high-fat meals land differently than they used to. Fatty takeaways, fried foods, rich creamy sauces, these can sit heavy, amplify nausea, and trigger the GI side effects (bloating, reflux, discomfort) that are most common in the early weeks of treatment. They're not banned; they're simply foods that carry a higher chance of making you feel rough, especially after a dose increase.
Refined carbohydrates eaten in large quantities (white bread, sugary drinks, cakes) tend to contribute calories without much satiety or nutritional return, and can cause blood-sugar swings that feel unpleasant when combined with the medicine's own glucose-regulating effects. Swapping them gradually for wholegrains, vegetables and fibre-rich options tends to smooth things out.
On the positive side: lean proteins, cooked vegetables, small portions of wholegrains, fruit, yoghurt, pulses and soups tend to be well tolerated and genuinely satisfying in the smaller portions that most people find themselves eating. Soft or warm foods often feel easier in the first few weeks. Cold foods (yoghurt, a small smoothie, chilled fruit) can also be gentle on an unsettled stomach. One patient-level resource worth bookmarking is the NHS healthy weight guidance, which gives sensible baseline principles that slot in well here.
If you're thinking about what all this means for your costs over time, the Mounjaro cost page explains how private treatment is priced and what's included.
One of the things people find surprising is that hunger signals become quieter (sometimes very quiet) on tirzepatide. Waiting until you're hungry to eat can mean skipping meals entirely, which tends to lead to lower protein intake, lower energy, and occasionally a dip into nausea because the stomach is empty for too long.
Eating on a loose schedule (breakfast, a mid-morning snack if needed, lunch, a light dinner) keeps energy steadier and makes it easier to hit adequate protein across the day without forcing large portions. Smaller, more frequent meals also reduce the likelihood of overeating at any single sitting, which on Mounjaro can cause real discomfort quickly. Our page on what happens if you overeat on Mounjaro covers that in more detail.
Equally, under-eating is a genuine risk when appetite falls sharply. Eating too little for too long can stall weight loss and leave you low on energy; the page on what happens if you don't eat on Mounjaro addresses this directly. A useful rule of thumb from the trial nutritional protocols: if a meal feels too large, put half on the plate and come back if genuinely still hungry. Rarely do people go back.
Practically, keeping the fridge stocked with go-to protein options (a pot of Greek yoghurt on the door shelf, some pre-cooked chicken or hard-boiled eggs) means that when appetite does show up briefly, the easiest thing to reach for is also the most useful thing nutritionally. Small habit, real difference.
Alcohol sits in a slightly awkward place on Mounjaro: it's not contraindicated, but it adds calories with no nutritional benefit, can lower inhibitions around food choices, irritates the GI tract (compounding nausea), and, in larger amounts, impairs the liver function that weight-loss treatment is partly trying to support. Most people find their alcohol tolerance reduces on treatment, smaller amounts have a more noticeable effect. Moderation is sensible; abstinence is not required but is a valid choice.
Caffeine is generally fine. Strong coffee on a completely empty stomach can sometimes worsen nausea early in treatment; having it with or shortly after a small meal tends to be better tolerated.
If you're still getting to grips with the treatment itself, our guide to what Mounjaro injections are and how they work is a helpful place to start before thinking about timing and routine. Mounjaro is injected once weekly, and the injection day itself has no specific food timing rule, unlike the oral Wegovy tablet, which requires an empty stomach. You can eat normally before and after your Mounjaro injection, and what matters more is consistency of dose day and rotation of injection site. If you're still building confidence with injections, the Mounjaro injection guide covers technique and site rotation clearly.
Your prescriber is the right person to discuss your specific diet, any existing conditions (such as type 2 diabetes, where carbohydrate management adds a further layer), and how your eating pattern is working as your dose progresses. If you'd like to explore whether treatment is right for you, speak to our prescribers through a free consultation, reviewed the same day by a GPhC-registered clinician, not automated software.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.